Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Mylan Laboratories
Approval Status: Approved June 1998
Treatment for: Burn Wounds

General Information

Sulfamylon Powder for 5% solution has been approved for use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds. This is the first drug approved for this indication.